- Added to Email Alerts
Chronic Leukemia
Latest News View All
-
CLL: Venetoclax Combos Top First-Line Chemoimmunotherapy
-
CLL: Black Patients Die Sooner Than White Patients
-
Frontline CLL Therapy: Avoiding Adverse Events
-
Relapsed CLL: New Approaches Prolong Survival
-
Ibrutinib Price Tag Keeps Rising, Despite Increased Competition
-
MRD: Powerful Metric for CLL Research
-
B-Cell Cancers: Sparse Insight Into Preventing Infections
-
CLL Treatment: More Infections Among Real-World Patients
Perspective View All
Journal Articles View All
-
Risks of Second Non-Breast Primaries Following Breast Cancer
-
Improving the Laboratory Evaluation of Monoclonal Gammopathies
-
How I Diagnose Mature T-Cell Proliferations by Flow Cytometry
-
Ibrutinib Plus Venetoclax for First-Line Treatment of CLL
-
Next-generation Antibody-based Therapies in Neurology
-
COVID-19 and Immune-Mediated RBC Destruction
Additional Resources
Medscape Drugs & Diseases
- Chronic Lymphocytic Leukemia Treatment Protocols
- Chronic Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Hairy Cell Leukemia
- Leukemias
Medscape Education